Literature DB >> 10993685

Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.

H Fujigasaki1, T Uchihara, S Koyano, K Iwabuchi, S Yagishita, T Makifuchi, A Nakamura, K Ishida, S Toru, S Hirai, K Ishikawa, T Tanabe, H Mizusawa.   

Abstract

Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3) is one of the dominantly inherited cerebellar ataxias. The gene responsible for the disease, a novel gene of unknown function, encodes ataxin-3 containing a polyglutamine stretch. Although it has been known that ataxin-3 is incorporated into neuronal intranuclear inclusions (NIIs) in neurons of affected regions, the relationship between NII formation and neuronal degeneration still remains uncertain. In the present study we show two different conditions in which ataxin-3 is recruited into the nucleus and suggest a process to form nuclear inclusions. In normal brains, wild-type ataxin-3 localizes within the ubiquitin-positive nuclear inclusion, the Marinesco body, indicating that ataxin-3 is recruited into the nuclear inclusion even in the absence of pathologically expanded polyglutamine. In MJD/SCA3 brains, immunohistochemical analyses with anti-ataxin-3 antibody, anti-ubiquitin antibody, and monoclonal antibody 1C2 known to recognize expanded polyglutamine revealed differences in frequency and in diameter among NIIs recognized by each antibody. These results were confirmed in the same inclusions by double immunofluorescent staining, suggesting that expanded ataxin-3 forms a core, thereby recruiting wild-type ataxin-3 into the nucleus around the core portion, and then followed by activation of the ubiquitin/ATP-dependent pathway. Recruitment of ataxin-3 into the nucleus and formation of nuclear inclusion under two different conditions suggest that ataxin-3 may be translocated into the nucleus under certain conditions stressful on neuronal cells such as aging and polyglutamine neurotoxicity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993685     DOI: 10.1006/exnr.2000.7479

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  18 in total

Review 1.  Molecular pathogenesis of spinocerebellar ataxia type 6.

Authors:  Holly B Kordasiewicz; Christopher M Gomez
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

2.  Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.

Authors:  Peter Breuer; Annette Haacke; Bernd O Evert; Ullrich Wüllner
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

3.  Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

Authors:  Andreia Neves-Carvalho; Elsa Logarinho; Ana Freitas; Sara Duarte-Silva; Maria do Carmo Costa; Anabela Silva-Fernandes; Margarida Martins; Sofia Cravino Serra; André T Lopes; Henry L Paulson; Peter Heutink; João B Relvas; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2014-08-20       Impact factor: 6.150

4.  The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.

Authors:  Barrington G Burnett; Randall N Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

5.  Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.

Authors:  U Nagaoka; T Uchihara; K Iwabuchi; H Konno; M Tobita; N Funata; S Yagishita; T Kato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

6.  Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line.

Authors:  Lauren R Moore; Laura Keller; David D Bushart; Rodrigo G Delatorre; Duojia Li; Hayley S McLoughlin; Maria do Carmo Costa; Vikram G Shakkottai; Gary D Smith; Henry L Paulson
Journal:  Stem Cell Res       Date:  2019-07-16       Impact factor: 2.020

7.  Proteotoxic stress increases nuclear localization of ataxin-3.

Authors:  Christopher P Reina; Xiaoyan Zhong; Randall N Pittman
Journal:  Hum Mol Genet       Date:  2009-10-19       Impact factor: 6.150

8.  Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.

Authors:  Sokol V Todi; K Matthew Scaglione; Jessica R Blount; Venkatesha Basrur; Kevin P Conlon; Annalisa Pastore; Kojo Elenitoba-Johnson; Henry L Paulson
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

9.  Ataxin-3 and its e3 partners: implications for machado-joseph disease.

Authors:  Thomas M Durcan; Edward A Fon
Journal:  Front Neurol       Date:  2013-05-06       Impact factor: 4.003

10.  Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Authors:  A Matilla-Dueñas; T Ashizawa; A Brice; S Magri; K N McFarland; M Pandolfo; S M Pulst; O Riess; D C Rubinsztein; J Schmidt; T Schmidt; D R Scoles; G Stevanin; F Taroni; B R Underwood; I Sánchez
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.